This review will discuss erectile dysfunction in prostate cancer patients following radical prostatectomy . It will focus on the prevalence and current treatments for erectile dysfunction as well as the emotional impact of erectile dysfunction and the current psychosocial interventions designed to help patients cope with this side effect.
INTRODUCTION
A wide range of erectile dysfunction rates following radical prostatectomy has been reported. In a metaanalysis of erectile dysfunction rates following radical prostatectomy, Tal and colleagues [1] reported rates that range from 14 to 90%, a range that is too broad to help inform prostate cancer treatment decision-making or quality postoperative counseling. Such discrepancies in prevalence are primarily because of important methodological differences in these studies. For example, poor quality studies use physician assessment of erectile function, define erectile function recovery as erections hard enough for penetration about 'half the time,' and use favorable subgroup analysis [1, 2] . Mulhall [3] similarly found the incidence of erectile dysfunction after radical prostatectomy was extremely discrepant, ranging from 12 to 96%, with higher rates in multicenter, multisurgeon series, compared with single center, single surgeon series. Mulhall [3] outlined recommendations for adequate reporting, ascertaining that the minimum requirements should include: comorbidity profile, patient selection process, data acquisition methods, questionnaires selection, baseline erectile function data, long-term erectile function data (>24 months), definition of adequate erectile function, proportions of men returning to normal, proportion of men returning to preoperative erectile function level, erectogenic medications use, and rehabilitation strategy.
The studies that have used sound methodologies have concluded radical prostatectomy has a severe impact on erectile function, and that erectile dysfunction rates are on the higher end of this spectrum. Schover et al. [4] reported in 1236 men, 4.3 years after early stage treatment, that 85% had problems with erections. This percentage is supported by a number of current, high-quality studies. Resnick and colleagues [5 && ] reported data from the Prostate Cancer Outcomes Study, a populationbased cohort study of men who were diagnosed with prostate cancer and were followed prospectively for 15 years since 1991. Of the 1655 men assessed at baseline and 2, 5, and 15 years after radical prostatectomy or radiation therapy, men undergoing prostatectomy were more likely to have erectile dysfunction at 2 years, and at 5 years, with 78 to 87% experiencing insufficient erections for intercourse [5 && ]. Similarly, Johansson [6] reported that of 173 men, 146 (84%) reported erectile dysfunction after radical prostatectomy. Lastly, Nelson et al. [7 & ] investigated the percentage of men who achieved 'back to baseline' erections following radical prostatectomy. In a longitudinal study of 134 men with normal erections presurgery, only 16% were able to obtain the quality of their presurgery erections 2 years after treatment. For men over 60 years of age, this decreased to only 4%. It is important to note that robotic surgical techniques have not improved the rate of erectile function recovery following radical prostatectomy. Robotic techniques were marketed suggesting that increased surgical precision would reduce side-effects; however, a recent meta-analysis found that new robotic techniques have not improved erectile dysfunction after radical prostatectomy [8].
MEDICAL TREATMENTS FOR ERECTILE DYSFUNCTION AND PENILE REHABILITATION FOLLOWING RADICAL PROSTATECTOMY
There are currently a variety of treatments for erectile dysfunction. The first-line therapy for erectile dysfunction is using phosphodiesterase-5 inhibitors (PDE5Is) (e.g., sildenafil, tadalafil, and vardenafil). Unfortunately, only about 12 to 17% of men will respond to these pills in the first 6 months following surgery [9] . The mechanism for erections is the secretion of nitric oxide from the cavernous nerves that run bilaterally along the prostate. Nitric oxide promotes smooth muscle relaxation in the penis, producing an erection. Phosphodiesterase-5 (PDE-5) is a chemical that breaks down nitric oxide, and as their name implies, oral medications inhibit PDE-5, leaving more nitric oxide available to produce an erection. Despite nerve-sparing surgical techniques [8, 10] , oral medications are generally ineffective early after surgery because the cavernous nerves are injured intraoperatively and can take 24 months to heal [11] . Early in the healing process, there is reduced nitric oxide secretion, which removes the mechanism of action for oral medications. As the nerves heal, they gradually start to secret nitric oxide and oral medications progressively become more effective.
Seeing that the cavernous nerves responsible for erection may take 18 to 24 months to heal postradical prostatectomy, natural erections via sexual stimulation and nocturnal erections may be absent during this recovery period [8, 12] . In a normal state, erections serve the purpose of pulling oxygen-rich blood into the penile tissue keeping this tissue healthy [12] . Men who fail to achieve natural erections postradical prostatectomy also fail to oxygenate their penile tissue, which can cause atrophy and permanent structural alterations [12, 13] . This may lead to venous leak which, once present, is irreversible and will cause erectile dysfunction [12] .
The process has led to the development of 'penile rehabilitation' to sustain penile tissue health following surgery. Penile rehabilitation programs instruct men to achieve medication-assisted erections 2 to 3 times a week (with or without the use sexual activity) immediately following radical prostatectomy in the 18 to 24-month recovery period. The theory is that consistent erections will pull oxygen-rich blood into the penile tissue, sustaining
KEY POINTS
Approximately 85% of men will report difficulties with erections following radical prostatectomy.
Penile rehabilitation should be the standard of practice for men with erectile dysfunction, following radical prostatectomy.
Men with prostate cancer report significant emotional distress related to erectile dysfunction.
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tissue health, and increasing the chance men will recover erections. As PDE5Is are ineffective after radical prostatectomy, penile injections have become a cornerstone of many rehabilitation programs. Data suggest that 52-67% of men who use a penile rehabilitation strategy recover erections compared with 20% of men who do not utilize penile rehabilitation [9, 14] . Penile rehabilitation is now the most common treatment for men following surgery, as 89% of sexual medicine professionals are utilizing some type of penile rehabilitation [1] . Vacuum devices to assist with erections have also been used in penile rehabilitation programs; however, there has been minimal research done on the effectiveness of vacuum devices for penile rehabilitation. If a man does not recover erections 24 months following radical prostatectomy, and penile injections or vacuum devices are not effective, penile implant surgery is an effective third-line therapy option [8].
POTENTIAL FUTURE TREATMENTS FOR ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
Alternative compounds have been suggested as potentially new treatments for erectile dysfunction, following radical prostatectomy [8]. These include triiodothyronine, rho kinase inhibitors, and stem cell therapy [15] [16] [17] . Another possibility that has been controversial is the use of testosterone treatment postprostatectomy [8] . Animal studies have shown that there may be an acute phase with hypogonadism after cavernous nerve damage [18] . Kim and colleagues [19] found that preoperative serum testosterone levels are positively correlated to postprostatectomy erectile functioning. Testosterone has also shown to regulate PDE-5 levels in rodents, and therefore may also improve response to PDE5Is in men with hypogonadism [20] . From these data, it has been speculated that a combination of testosterone and a PDE5I may aid in penile rehabilitation. Vignozzi et al. [18] found that when tadalafil was combined with testosterone in rats after bilateral nerve resection, penile oxygenation was restored and fibrosis was prevented, but hypoxia, however, was not prevented.
In human studies, Spitzer et al. [21] found that in men with low-testosterone levels there was nitric oxide benefit of combining testosterone and sildenafil, compared with sildenafil and a placebo. In a comprehensive review, Buvat [22] [23] [24] found that only young patients with testosterone deficiency experienced a consistent benefit from testosterone therapy. Recent small studies have suggested that testosterone therapy can be given to men following radical prostatectomy without increasing the risk of disease recurrence or disease progression. Although the concept of testosterone in penile rehabilitation has potential, more clinical trials are needed to determine its efficacy in aiding in erectile function recovery [8] .
AVOIDANCE AND DIFFICULTY SUSTAINING ERECTILE DYSFUNCTION TREATMENTS
Although there are effective treatments for erectile dysfunction, many men avoid seeking medical help for this condition. In a study of men (noncancer sample), who were found to have erectile dysfunction, 69% of men did not accept that they had erectile dysfunction and the median time to pursue treatment for erectile dysfunction was 2 years [25] . In men with prostate cancer, a study found that only 50% of men who were interested in seeking treatment for erectile dysfunction actually took steps to find treatment [26] . Of men who seek help to treat their erectile dysfunction, compliance is poor. It is estimated that 50 to 80% of men discontinue their use of erectile dysfunction treatments within a year of starting them [4, [27] [28] [29] . This applies to men with and without prostate cancer. Considering the importance of penile rehabilitation following prostate cancer surgery, the difficulty initiating and sustaining treatment could have a negative impact on men's ability to recovery erections following radical prostatectomy.
EMOTIONAL AND RELATIONSHIP IMPACT OF ERECTILE DYSFUNCTION
The most probable cause for the avoidance and lack of compliance with erectile dysfunction treatment is the emotional distress related to having erectile dysfunction [30 & ]. Research has established that there is an association between erectile dysfunction and emotional distress [31] [32] [33] [34] [35] [36] . The rate of depression in men with erectile dysfunction has been reported to be as high as 56%, and the relationship between erectile dysfunction and depression has been demonstrated in three large, well designed, population-based studies of aging men in the USA, Finland, Brazil, Japan, and Malaysia [32, 33, 37] . Although some authors have hypothesized that the life-saving nature of cancer treatments may mitigate the distress men experience related to erectile dysfunction, studies focusing on men following prostate cancer treatment have confirmed the relationship between erectile dysfunction, and distress and depression [6, 34, 38] . For example, Johansson and colleagues [6] found that 37% of men report high distress because of a loss of erectile function following prostate cancer surgery. Additionally, Nelson et al. [36] found that men reported significant shame and embarrassment as well as a reduction in general life happiness related to their erectile dysfunction following surgery. This distress seems to be related to the construct of male sexual or masculine identity. Men who have a high sexual self-schema pretreatment are especially vulnerable to find the loss of sexual function distressing and show increased depressive symptoms when they experience erectile dysfunction [39 & ]. Zaider et al. [40] found that around one-third of men assert that they have a moderate-to-severe loss of masculinity after treatment for localized prostate cancer.
Even more problematic is that this psychological burden because of erectile dysfunction can lead to problems between the patients and their partners, such as poor marital adjustment [38, [41] [42] [43] [44] . Both sexual and non-sexual loss of intimacy can occur and lead to relationship distress, conflict, and frustration [38, 45] . Couples often use avoidant strategies and put off seeking help for this marital distress [46] . This avoidance may seem useful at the time to circumvent dealing with the stressful problems of cancer and sexual dysfunction. However, as healthy spousal communication has been associated with greater marital adjustment in dealing with prostate cancer and erectile dysfunction, seeking help, and developing healthy communication would be the optimal strategy [46, 47] .
PSYCHOSOCIAL INTERVENTIONS FOR ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
As the impact of erectile dysfunction goes beyond the physical and also affects psychological and relationship aspects, a few recent psychosocial interventions have taken a biopsychosocial approach to assisting men with sexual functioning after prostate cancer treatment. The results from these studies have generally proven to increase erectile dysfunction medical treatment use, whereas only minimally inducing long-term erectile function or psychosocial improvements. Chambers and colleagues [48] studied telephone based, couples interventions in Australia designed to improve couples' psychosexual adjustment after treatment for prostate cancer. They compared the efficacy of a couples-based, peerdelivered telephone support intervention versus a couples-based, nurse-delivered telephone counseling intervention versus usual care. The peer-delivered intervention utilized a peer support framework in which couples bolster support based on shared personal experiences, whereas the nurse-delivered counseling followed theoretical principles and techniques of cognitive-behavioral sex and couples therapy. Men who were scheduled for, or who had undergone surgery for prostate cancer, within the last 12 months of the study and their female partners were included. Significant effects in the intervention arms were found for patients on sexual function and sexual self-confidence. Significant differences among intervention arms for overall use of medical treatments for erectile dysfunction at 12-month follow-up were also reported. Patients in both the peer and nurse-driven interventions were over 3 times more likely to use medical treatments for erectile dysfunction than those in usual care.
Schover and colleagues [49] developed and tested the counseling about regaining erections and sexual satisfaction intervention, a psychosocial program designed to address sexual functioning following prostate cancer treatment. In this study, the researchers compared a face-to-face intervention to an internet-based intervention. The internet-based intervention was created to be more convenient, to minimize dropout rates, and to play to the fact that many men already seek sexual content on the internet. Men with localized prostate cancer, who were married or living with a partner for over a year and who had either definitive surgery or radiation therapy within 7 years of starting the study, were included. There were no differences in the study outcomes between the face-to-face and the internet-based groups, therefore, the two groups were combined for repeated measures analyses. Men who received the counseling about regaining erections and sexual satisfaction (face-toface or internet based) intervention had significant improvement in erectile function between baseline and the 6-month follow-up as well as between baseline and the 1-year follow-up. Approximately, 16% had near-normal function at baseline, which increased to 39% at 6 months, then declined slightly to 35% at 1-year follow-up. Men in the intervention conditions also improved significantly on the subscales of orgasmic function, intercourse satisfaction, and overall sexual satisfaction from baseline to 1 year. Men who intensified their erectile dysfunction treatment had large, significant increases in erectile function scores across time.
Siddons et al. [50] conducted a randomized, wait-list control trial to evaluate a cognitive-behavioral therapy group intervention to facilitate improved psychosexual adjustment to treatment side-effects for prostate cancer survivors who had undergone radical prostatectomy. In total, 60 men participated across nine cognitive behavioral groups, and completed a manualized 8-week cognitive-behavioral group intervention. All participants were 6 months to 5 years postradical prostatectomy for localized prostate cancer. Standardized questionnaires preintervention and postintervention were completed, which assessed quality of life, psychological distress, prostate cancer anxiety, and sexual functioning. Significant preintervention to postintervention improvement was found on sexual confidence, masculine selfesteem, and relationship functioning. There was no change on engagement in sexual activities, sexual Intimacy, or marital affection. After controlling for covariates, hierarchical regression analyses revealed participation in the group intervention significantly improved sexual confidence, sexual self-esteem, masculine self-esteem, and satisfaction with orgasm.
CONCLUSION
Although prostate cancer surgery can have a significant negative impact on erectile function, there are a number of medical treatments available to address erectile dysfunction. The state-ofart medical practice following prostate cancer surgery includes the concept of penile rehabilitation where penile tissue health is maintained by consistently using erectogenic treatments for approximately 18-24 months following surgery. However, patients have difficulty maintaining compliance with erectile dysfunction treatments and penile rehabilitation. This difficulty is related to the negative emotional and relational impact erectile dysfunction can have on both the patient and the partner. Psychosocial interventions have taken a biopsychosocial approach and demonstrated initial efficacy in helping men maintain the use of erectile dysfunction treatments following radical prostatectomy. Although these interventions have demonstrated promise, continued work needs to be done to advance a 'combined' approach, where medical treatments and psychosocial interventions are used together to improve outcomes for these patients.
